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OBJECTIVE—Proinflammatory cytokines are cytotoxic to -cells
and have been implicated in the pathogenesis of type 1 diabetes and
islet graft failure. The importance of the intrinsic mitochondrial
apoptotic pathway in cytokine-induced -cell death is unclear. Here,
cytokine activation of the intrinsic apoptotic pathway and the role
of the two proapoptotic Bcl-2 proteins, Bad and Bax, were exam-
ined in -cells.
RESEARCH DESIGN AND METHODS—Human and rat islets
and INS-1 cells were exposed to a combination of proinﬂamma-
tory cytokines (interleukin-1, interferon-, and/or tumor necro-
sis factor-). Activation of Bad was determined by Ser136
dephosphorylation, mitochondrial stress by changes in mito-
chondrial metabolic activity and cytochrome c release, down-
stream apoptotic signaling by activation of caspase-9 and -3, and
DNA fragmentation. The inhibitors FK506 and V5 were used to
investigate the role of Bad and Bax activation, respectively.
RESULTS—We found that proinﬂammatory cytokines induced
calcineurin-dependent dephosphorylation of Bad Ser136, mito-
chondrial stress, cytochrome c release, activation of caspase-9
and -3, and DNA fragmentation. Inhibition of Bad Ser136 dephos-
phorylation or Bax was found to inhibit cytokine-induced intrin-
sic proapoptotic signaling.
CONCLUSIONS—Our ﬁndings demonstrate that the intrinsic
mitochondrial apoptotic pathway contributes signiﬁcantly to
cytokine-induced -cell death and suggest a functional role of
calcineurin-mediated Bad Ser136 dephosphorylation and Bax
activity in cytokine-induced apoptosis. Diabetes 58:
1807–1815, 2009
P
roinﬂammatory cytokines, particularly interleu-
kin (IL)-1 in combination with interferon
(IFN)- and/or tumor necrosis factor (TNF)-,
have been implicated in the elimination of -cells
in type 1 diabetes (1). However, the exact molecular
mechanisms by which proinﬂammatory cytokines induce
-cell death are not clear. While several signaling path-
ways have been suggested to play a role in cytokine-
mediated cell death (1), it remains unclear how these
pathways cooperate to induce apoptosis in -cells. Fur-
thermore, it is still debated whether cell death induced by
proinﬂammatory cytokines occurs by necrosis, apoptosis,
or both.
Apoptosis is an energy-dependent process in which dying
cells activate a genetically encoded cell-death program. Es-
sential in this process is the caspase family of cysteine
proteases (2). Signals activating the “intrinsic apoptotic path-
way” converge on the mitochondria, leading to mitochondrial
membrane permeabilization and subsequent release of cyto-
chrome c from the intermembranous space (3). Once in the
cytosol, cytochrome c complexes with apoptosis-protease
activating factor-1, which, in the presence of ATP, leads to
activation of the initiator caspase, caspase-9. Through pro-
teolytic cleavage, caspase-9 activates the effector caspase,
caspase-3, leading to cleavage of numerous cellular targets
and resulting in the systematic dismantling of the cell (4).
The release of cytochrome c from the mitochondria is
regulated by the Bcl-2 family of proteins (5). The proapop-
totic Bcl-2 proteins can be subdivided into “multidomain”
and “BH3-only” proteins. Multidomain proapoptotic pro-
teins, such as Bax and Bak, contain the conserved Bcl-2
homology (BH) domains 1–3. Upstream of the multido-
main proteins are the BH3-only proapoptotic proteins,
such as Bid and Bad, which contain only the amphipathic
-helical BH3 domain. Antiapoptotic Bcl-2 family mem-
bers contain all four BH domains (BH1–4) and are gener-
ally thought to prevent apoptosis by sequestering the
proapoptotic Bcl-2 proteins, although the exact mecha-
nisms remain elusive (6).
The proapoptotic multidomain proteins Bax and Bak are
essential in mitochondrial dysfunction and cell death
caused by a variety of stimuli (7). During apoptosis, Bax
changes conformation and translocates from the cytosol
to the mitochondria where it, along with Bak, mediates
mitochondrial permeabilization and the release of cyto-
toxic proteins such as cytochrome c. Although the precise
mechanism of mitochondrial permeabilization by proapop-
totic Bcl-2 proteins is unclear, this step represents a
critical checkpoint for survival, beyond which the cell is
committed to death (3).
Under normal conditions, the BH3-only protein Bad is
sequestered in the cytosol by binding to proteins of the
14-3-3 family of phospho-Ser/Thr–binding proteins, and
this interaction is dependent upon phosphorylation of Bad
at Ser112 and Ser136 (8). Following certain apoptotic
stimuli, Bad is dephosphorylated, leading to its dissocia-
tion from 14-3-3. Dephosphorylated Bad can bind anti-
apoptotic proteins such as Bcl-XL or Bcl-2 and is thought
to block their antiapoptotic function (8,9). The antiapop-
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DIABETES, VOL. 58, AUGUST 2009 1807totic/survival kinase Akt phosphorylates Bad at Ser136
(8,10), while the Ca
2-dependent phosphatase calcineurin
dephosphorylates this residue (and Ser112) in response to
increased intracellular Ca
2 concentrations (11). In addi-
tion, the c-Jun NH2-terminal kinase (JNK) can phosphory-
late 14-3-3, resulting in 14-3-3/Bad dissociation, which is
followed by Bad dephosphorylation and activation (12).
Thus, the control of Bad phosphorylation provides a
sensitive means of regulating cell survival (13).
There is accumulating evidence for a role of the mito-
chondrial pathway in proinﬂammatory cytokine–induced
cell death in pancreatic -cells. A combination of IL-1,
IFN-, and TNF- has been shown to induce mitochondrial
membrane depolarization in rat RINm5F cells (14), and
IL-1 induced cytochrome c release from the mitochon-
dria and caspase-9 activity in rat islets (15). In addition,
IFN- and TNF- induced Bad dephosphorylation at
Ser112, release of cytochrome c, caspase activation, and
cell death in mouse MIN6N8 cells (16). A role for the Bcl-2
proteins in cytokine-induced -cell death has been sug-
gested because the mRNA expression of several Bcl-2
members is regulated by IL-1 plus IFN- exposure in
INS-1E cells (17), IL-1 induces translocation of Bax out of
the cytosol in rat islets (15), and overexpression of anti-
apoptotic Bcl-2 members protects against the -cell cyto-
toxic effects of proinﬂammatory cytokines (14,18–23).
It is not known how IL-1 potentiated by IFN-/TNF-
signals to the mitochondria in -cells. Following exposure
of -cells to IL-1 or IL-1 plus IFN-, JNK activity and
intracellular Ca
2 concentrations are increased (24–26),
whereas Akt activity is decreased (27). These events may
be crucial in IL-1–induced proapoptotic signaling, since
inhibition of JNK activity and Ca
2-induced signaling
prevent cytokine-induced -cell death (26,28). Stimulation
of Akt by survival factors (e.g., IGF) also protects -cells
from cytokine-induced apoptosis (27). However, the mo-
lecular mechanisms downstream of JNK, Akt, and Ca
2 in
cytokine-induced -cell death are not clear. The aim of this
study was therefore to examine the contribution of the
intrinsic mitochondrial pathway to cytokine-induced cell
death and the role of Bax and Bad in this process.
RESEARCH DESIGN AND METHODS
Cell culture. The clonal rat -cell line INS-1 (a gift from Prof. Claes Wollheim,
Geneva, Switzerland) was cultured at 37°C in a humidiﬁed atmosphere of 5%
CO2 in complete RPMI-1640 medium (RPMI-1640 with glutamax [Invitrogen],
11 mmol/l glucose, 50 mol/l -mercaptoethanol, 100 units/ml penicillin, and
100 g/ml streptomycin) supplemented with 10% FBS. When conﬂuent, cells
were trypsinized and seeded for culture and experiments. In experiments with
INS-1 cells and rat islets, IL-1 (160 pg/ml) and IFN- (5 ng/ml) were used,
while with human islets IL-1 (2 ng/ml), IFN- (100 ng/ml), and TNF- (100
ng/ml) were used. Recombinant mouse IL-1 was from BD Bioscience
PharMingen, and recombinant rat IFN-, recombinant human IL-1, recombi-
nant human IFN-, and recombinant human TNF- were from R&D Systems.
The combination and concentrations of cytokines were selected based on
their ability to induce a four- to ﬁvefold increase in apoptosis over background
levels. The V5 Bax inhibitory peptide VPMLK (University of Calgary Peptide
Synthesis, Calgary, Canada, and Calbiochem) was used at 100 mol/l. FK506
(Tacrolimus) from Sigma was used at 1 mol/l. In experiments examining the
potentially protective effect of a compound, the compound was added 30–60
min prior to cytokines. For all compounds prepared in DMSO, the ﬁnal
concentration of DMSO in the culture media was kept below 0.1%. Appropri-
ate vehicle controls were prepared for all treatments.
Rat islet isolation. Pancreata from 5- to 7-day-old outbred Wistar rats
(Taconic) were collagenase digested, and islets were isolated by Percoll
gradient puriﬁcation (GE Healthcare). Five hundred or 1,000 islets were
cultured for 5–7 days in complete RPMI-1640 medium with 10% FCS at 37°C
in a humidiﬁed atmosphere of 5% CO2 before stimulation in complete
RPMI-1640 medium with 0.5% human serum.
Human islet isolation. Pancreata were retrieved from heart-beating cadav-
eric donors at the time of multiorgan harvest for transplantation, and islets
were isolated as described previously (28). The number of islet equivalents
(IEQs) and islet purity were assessed using dithizone (Sigma). Glucose-
stimulated insulin secretion was routinely assessed to ensure islet function-
ality. Isolated human islets (85% purity) were cultured in CMRL-1066
medium (Life Technologies) containing 10% FBS (Wisent) at 37°C in a
humidiﬁed atmosphere of 5% CO2. Medium was changed every other day.
Immunoblotting. Immunoblotting was performed as described previously
(24,28). Brieﬂy, lysate protein concentrations were measured by the Bradford
method according to the manufacturer’s instructions (Bio-Rad). Equivalent
amounts of protein from each condition were immunoblotted as described by
the manufacturer (Invitrogen), and the protein of interest was detected by
chemiluminescence. Anti–cytochrome c (BD Biosciences) was used at a
dilution of 1:1,000; anti–cleaved caspase-3 (Cell Signaling Technology) at
1:250–1,000; anti-Bax (Santa Cruz Biotechnology) at 1:800; anti–cytochrome c
oxidase subunit IV (COX4) (BD Biosciences) at 1:500; pBads136 (Biosource)
at 1:250; anti–phospho-JNK and total-JNK (Cell signaling) at 1:1,000; anti-actin
(Abcam or Chemicon) at 1:10,000 or 1:1.000, respectively; anti-tubulin (Santa
Cruz Biotechnology) at 1:1,000; and anti–cleaved caspase-9 (Cell Signal-
ing Technology) at 1:500. Horseradish-peroxidase–conjugated anti-rabbit (1:
2,000) and anti-mouse (1:1,000) were purchased from Cell Signaling Technol-
ogy. Ponceau staining (Fluka biochemika) was used in Fig. 7E to show equal
loading.
Caspase-activity assays
DEVDase assay. To assess caspase-3–like protease activity, cleavage of the
colorimetric substrate DEVD-pNA was measured as previously described (28).
In short, the supernatant of islet sample lysates (2,000 IEQ) was used for
analysis. Following determination of the protein content (Bio-Rad), the
release of pNA was analyzed by measuring the absorbance at 405 nm using a
Benchmark Microplate Reader (Bio-Rad).
Caspase-9 assay. To assess caspase-9 activity, luciferase activity dependent
on caspase-9–mediated generation of luciferase substrate was measured.
Brieﬂy, 25 rat islets or 1  10
6 INS cells were exposed to cytokines for 24 h.
Caspase-Glo reagent (Caspase-Glo; Promega) was added directly to islet
cultures or to INS cells following removal of the medium, and light emission
was detected after 30 min using a VictorX Light (PerkinElmer).
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay
Aliquots containing 500 IEQ in 500 l of medium were placed in sterile
Eppendorf tubes, and 50 l of stock 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide (MTT) (5 mg/ml) (Sigma) was added to each sample.
The samples were incubated at 37°C for 2 h, washed twice with cold PBS, and
lysed with 200 l of DMSO (Sigma). Aliquots of 100 l from each sample were
transferred to a 96-well plate, and the absorbance was measured at 595 nm
using a Benchmark Microplate Reader (Bio-Rad). Four independent samples
were analyzed per experiment, and each experiment was repeated at least
three times.
Insulin assay
For measurement of glucose-stimulated insulin release, cultured human islets
(100 IEQ per group in duplicate) were washed with CMRL-1066 and incubated
in Hank’s buffered saline containing 2.2 mmol/l glucose for two consecutive
periods of 60 min at 37°C. Next, islets were incubated for 30 min with 22
mmol/l glucose and then another 30 min with 22 mmol/l glucose and 50 mol/l
3-isobutyl-1-methylxanthine (IBMX), an inhibitor of cyclic AMP phosphodies-
terase. Finally, islets were washed with Hank’s buffered saline and incubated
f o r1hi n2 . 2mmol/l glucose. The supernatants were kept following each
incubation and analyzed for insulin content using a commercially available
insulin enzyme-linked immunosorbent assay kit (Crystal Chem). Insulin
release was normalized to the protein content of the pellet determined using
a Bio-Rad Protein Assay Dye Reagent. For measurement of accumulated
insulin release, 150 rat islets were cultured in 1 ml of medium. Following 24 h
of cytokine exposure, accumulated insulin in the incubation medium was
measured as previously described (29).
Subcellular fractionation
Cytosolic and mitochondria-enriched fractions were prepared using an ApoA-
lert Cell Fractionation Kit according to the manufacturer’s directions (BD
Biosciences). Brieﬂy, islet samples (8,000 IEQ) were resuspended in fraction-
ation buffer (BD Biosciences) and incubated on ice for 10 min. Cells were then
homogenized on ice using 100 passes with a dounce tissue grinder. The
resulting homogenate was centrifuged at 3,000 rpm for 10 min, and the
supernatant was kept. The supernatant was centrifuged at 12,000 rpm for 25
min, and the resulting supernatant was the cytosolic fraction. The mitochon-
dria-enriched pellet was resuspended in 10 l fractionation buffer. The protein
content was determined using a Bio-Rad Protein Assay Dye Reagent.
Cell death detection assay
As a marker for apoptosis, histone/DNA complexes released from the nucleus
to the cytosol were measured according to the manufacturer’s instructions
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PLUS; Roche). In short, cell lysates were incubated
with anti–DNA-peroxidase and anti–histone-biotin and transferred to strepta-
vidin-coated wells. Absorbance was measured after addition of the peroxidase
substrate ABTS (2,2-azino-bis-3-ethylbenzthiazoline-6-sufonate).
Statistical analysis
Data are presented as means 	 SE. Statistical signiﬁcance was determined by
Student’s paired t test (on the planned comparisons reported) or by two-way
ANOVA with Dunnett’s post hoc test (time course experiments) (Figs. 3A and
5A), with P 
 0.05 as the level of signiﬁcance.
RESULTS
Cytokines induce Bax-dependent mitochondrial
stress. To investigate if cytokines induce mitochondrial
stress in human islets, we investigated the effects of
cytokine exposure on mitochondrial cytochrome c release
and mitochondrial metabolic activity. We used cell frac-
tionation followed by immunoblotting to observe a move-
ment of cytochrome c from the mitochondrial fraction into
the cytosolic fraction after cytokine exposure (Fig. 1A and
B). Immunoblotting for COX4 was used to conﬁrm that the
cytosolic fractions were not contaminated with mitochon-
drial proteins. Cytokine exposure also led to a signiﬁcant
decrease in mitochondria metabolic activity examined
with the MTT assay (Fig. 1C).
To examine if cytokine-mediated mitochondrial dys-
function is mediated by Bax, we used the Bax inhibitory
peptide V5. The V5 peptide is derived from the Bax-binding
domain of human Ku70 (30). Ku70 binds Bax in the cytosol
and prevents the proapoptotic functions of Bax by inhib-
iting Bax translocation to the mitochondria (31,32). In
analogy, V5 binds Bax, inhibits Bax activation (proapop-
totic conformational change), and suppresses apoptosis
(30,33). To conﬁrm that V5 can efﬁciently enter cells within
an islet, isolated human islets were treated with 5-FAM
(6-carboxy-ﬂuorescein)–labeled V5. When treated islets
were washed and dispersed into single cells, all cells were
found to contain the labeled peptide localized mainly to
the cytosol (confocal microscopy) (data not shown). Im-
munoblot analysis of cytosolic and mitochondria-enriched
fractions showed that V5 decreased cytokine-induced cy-
tochrome c release from the mitochondria into the cytosol
(Fig. 1A). V5 was also able to protect human islets against
cytokine-induced inhibition of mitochondrial function
(Fig. 1B), whereas a negative control peptide had no effect
(Calbiochem) (data not shown). Taken together, these
ﬁndings demonstrate that inﬂammatory cytokines induce
Bax-mediated mitochondrial dysfunction and cytochrome
c release.
V5 does not affect glucose-stimulated insulin release
but reduces cytokine-mediated inhibition of accumu-
lated insulin release. Perturbations in mitochondrial
function and integrity can lead to defective insulin secre-
tion (34). Overexpression of Bcl-XL has previously been
shown to impair insulin secretion and was associated with
altered mitochondrial polarization and Ca
2 signaling in
response to glucose (35). We therefore examined whether
V5 affected glucose-stimulated insulin release in isolated
human islets. Freshly isolated islets were cultured for 48 h
in the presence of 100 mol/l V5, and glucose-stimulated
insulin release was assessed. V5 had no effect on basal
insulin release at low glucose levels or on insulin release in
response to high glucose (Fig. 2A). Addition of IBMX, an
inhibitor of cyclic AMP phosphodiesterase, causes ele-
vated intracellular cyclic AMP levels that lead to increased
exocytosis of insulin (36). IBMX-induced insulin release
was unaffected by V5 treatment (Fig. 2A). Furthermore, V5
did not affect regulation of insulin secretion following a
return to low glucose levels (Fig. 2A). Therefore, V5 did
not adversely affect glucose-stimulated insulin secretion
from isolated human islets.
It has been demonstrated previously that cytokines
inhibit insulin release (1). Having established that V5 did
not affect glucose-stimulated insulin release, we next
asked whether V5 affected cytokine-mediated inhibition of
insulin release from rat islets. Thus, the effect of cytokines
on accumulated insulin in the culture medium released
from rat islets during 24 h incubation in the presence or
absence of V5 was measured. As seen in Fig. 2B, the
inhibitory effect of cytokines on accumulated insulin re-
lease was reduced by V5.
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FIG. 1. Cell-permeable V5 inhibits cytokine-induced cytochrome c
release and improves mitochondrial metabolic activity in human islets.
Cells were pre-exposed to V5 (100 mol/l) for 1 h before exposure
to cytokines for 24 h. A and B: Immunoblotting was performed on
fractionated cell lysates from human islets to assess the cellular
localization of cytochrome c. COX4, a mitochondrial protein, was used
as a control for the fractionation. Quantiﬁcations are shown as the
ratio of cytosolic to mitochondrial cytochrome c (A). Representative
gels from three independent experiments are shown (B). C: Changes in
the mitochondrial activity in human islets were measured with the MTT
assay as described in RESEARCH DESIGN AND METHODS. Bars represent
means  SE for ﬁve independent experiments. *P < 0.05, ** P < 0.01
vs. treatment without cytokines.
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activation of caspase-9. To verify the cytokine-induced
activation of caspase-9 in INS-1 cells and rat islets, we
used an antibody speciﬁc for cleaved caspase-9 and a
caspase-9 activity assay. The combination of IL-1 and
IFN- caused a time-dependent cleavage of caspase-9 in
INS-1 cells, which was signiﬁcant after 12 h of cytokine
exposure (Fig. 3A). In rat islets, caspase-9 was cleaved
with slower kinetics than in INS-1 cells (Fig. 3C). In both
INS-1 cells (Fig. 3B) and rat islets (Fig. 3D), cleavage of
caspase-9 was associated with increased caspase-9 activ-
ity. In contrast, we observed that caspase-8 was activated
not by the combination of IL-1 and IFN- but only when
TNF- was added to this combination (data not shown).
Cytokine-induced -cell toxicity is inhibited by V5.
We observed caspase-3 cleavage after 24 h of cytokine
exposure in INS-1 cells (Fig. 4A) and in human islets (Fig.
4B). To assess if caspase-3 activation depended upon Bax
activity, we examined the effect of the V5 inhibitor on
caspase-3 cleavage and DEVDase activity, indicative of
caspase-3–like protease activity. In both human islets and
INS-1 cells, cytokine-induced processing of caspase-3 to
its cleaved (active) form was inhibited by pre-exposure to
V5 for 1 h (Fig. 4A and B). Cytokine treatment for 24 h
resulted in a nearly fourfold increase in DEVDase activity,
and this effect was inhibited by V5 pretreatment (Fig. 4C).
Furthermore, pre-exposure to V5 decreased cytokine-
induced oligonucleosomal fragmentation after 24 h—a
marker of apoptosis (Fig. 4D). Taken together, these
results suggest that Bax-mediated mitochondrial perme-
abilization is important in cytokine-induced islet cell
death.
Cytokines induce dephosphorylation of Bad Ser136.
To examine the role of Bad in cytokine-induced Bax
activation and apoptosis signaling, we investigated the
effects of cytokine exposure on Bad Ser136 dephosphory-
lation. In INS-1 cells, IL-1 plus IFN- induced a time-
dependent dephosphorylation of Bad Ser136 (Fig. 5A)
without affecting Bad protein expression (data not
shown). In rat islets, exposure to IL-1 plus IFN- induced
Bad Ser136 dephosphorylation (Fig. 5B) with slower ki-
netics than in INS-1 cells. We were unable to detect
phospho-Bad Ser136 in human islets (data not shown). In
line with the fact that Bad acts upstream of Bax activation
(3), we found that cytokine-induced Bad Ser136 dephos-
phorylation was unaffected by V5 (Fig. 5C).
Calcineurin is involved in cytokine-induced Bad
dephosphorylation. The Ca
2-activated Ser/Thr phos-
phatase calcineurin dephosphorylates Bad, leading to in-
duction of apoptosis (11). To investigate if IL-1IFN-
–induced dephosphorylation of Bad Ser136 was mediated
by calcineurin, we pre-exposed -cells to the calcineurin
inhibitor FK506 1 h before cytokine stimulation for 24 h.
As seen in Fig. 6, FK506 inhibited IL-1IFN-–induced
dephosphorylation of Bad Ser136 in both INS-1 cells (Fig.
6A) and rat islets (Fig. 6B), suggesting that calcineurin is
important in IL-1IFN-–induced dephosphorylation of
Bad Ser136. Since increased intracellular Ca
2 concentra-
tions induce calcineurin activity (37), we examined the
effect of Ca
2 inﬂux induced by KCl. We found that a 24-h
exposure to KCl (50 mmol/l) induced dephosphorylation
of Bad Ser136 equal to that induced by IL-1IFN-
in INS-1 cells but did not affect IL-1IFN-–induced
Bad Ser136 dephosphorylation (data not shown). These
data support a role of calcineurin in Bad Ser136
dephosphorylation.
Inhibition of calcineurin decreases cytokine-induced
-cell death. To investigate if calcineurin-mediated Bad
dephosphorylation causes cytokine-induced cell death, we
examined whether pre-exposure to FK506 inhibited
cytokine-induced -cell death. In rat islets, FK506 inhib-
ited cytokine-induced cleavage of caspase-3 (Fig. 7A).
Accordingly, FK506 decreased cytokine-induced DEVDase
activity in human islets (Fig. 7B). FK506 also improved
mitochondrial function and decreased apoptosis caused
by cytokine exposure in human islets (Fig. 7C and D). To
demonstrate that the protective effect of FK506 was not
due to inhibition of JNK, as has been observed elsewhere
(38), we examined the effect of FK506 on JNK phosphor-
ylation, which is necessary for IL-1–induced apoptosis
(1). As shown in Fig. 7E, FK506 did not affect cytokine-
induced JNK phosphorylation or JNK expression. Taken
together, these ﬁndings demonstrate that proinﬂammatory
cytokines induce calcineurin-mediated dephosphorylation
of Bad Ser136, leading to cell death.
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In this study, we demonstrate that cytokines induce 1)
dephosphorylation of Bad on Ser136 in INS-1 and rat islet
cells, 2) Bax-dependent release of cytochrome c and
inhibition of mitochondrial metabolic activity in human
islets, 3) cleavage/activation of caspase-9 in INS-1 cells
and rat islets and cleavage/activation of caspase-3 in INS-1
cells and rat and human islets, and ﬁnally 4) -cell
apoptosis in INS-1 cells and rat and human islets. Taken
together, our ﬁndings strongly suggest that cytokines
induce -cell apoptosis through the canonical intrinsic
mitochondrial pathway.
It has been suggested that cytokine-induced -cell death
is independent of Bax or Bak since siRNA-mediated
knockdown of Bax or Bak failed to affect cytokine-
induced cell death (39). In that study, the combination of
IL-1 and IFN- was found to induce cell death in INS-1–
derived cell lines and rat islets via nonapoptotic killing,
which is in contrast to our present observations. However,
the INS-1–derived cells used previously (39) were stably
transfected with the human proinsulin gene and were
selected for G418 resistance (40), which may well affect
the sensitivity to cytokines, as observed by Chen et al.
(41). Another discrepancy between the studies is the
markedly higher concentrations of cytokines used by
Collier et al. (39) than in our study, which may preferen-
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oxygen species/nitric oxide [NO]), while -cell apoptosis
may primarily be induced at lower concentrations. Thus,
Bax could be required for cytokine-induced -cell apopto-
sis but not for cytokine-induced nonapoptotic -cell kill-
ing. Further studies are needed to clarify the relative
importance of apoptosis versus necrosis, which may de-
pend on the model system used and the particular combi-
nation and concentration of proinﬂammatory cytokines.
A certain functional redundancy exists between Bax and
Bak (7). Thus, while we show that inhibition of Bax alone
decreased cytokine-induced -cell death, the combined
targeting of Bax and Bak may afford greater protection. In
addition to the intrinsic pathway investigated in this study,
apoptosis may also be induced by activation of the extrin-
sic (death receptor induced) pathway through caspase-8–
mediated caspase-3 cleavage. In -cells, TNF-, but not
IL-1, induces activation of caspase-8 (15,42), indicating
that TNF- is able to activate the extrinsic pathway. In
agreement with this, we observed that caspase-8 is acti-
vated by TNF-IL-1IFN- but not by IL-1IFN-
only (data not shown). In some cell types, the extrinsic
pathway must activate the intrinsic pathway to induce cell
death through caspase-8–mediated cleavage of the BH3-
only Bcl-2 protein Bid. Bid is required for the potentiating
effects of TNF- on IL-1IFN-–induced DNA fragmen-
tation in primary mouse islets (43), indicating that the
intrinsic pathway is important for TNF-–mediated -cell
death. Overall, the relative dependence of cytokine-
induced cell death on the extrinsic and intrinsic pathways
remains unclear, mostly due to an incomplete understand-
ing of how these pathways interact.
Because of its regulation by both prosurvival and apo-
ptotic signals, Bad may act as a survival switch between
-cell death and survival. Thus, in other cell systems,
antiapoptotic Akt signaling induces Bad Ser136 phos-
phorylation and inactivation (13), whereas proapoptotic
JNK signaling and increased intracellular Ca
2 concentra-
tion induce Bad Ser136 dephosphorylation and activation
(11,12). This notion may be of special relevance in
cytokine-induced -cell death because cytokines decrease
Akt activity (27), induce JNK activity (28), and increase
intracellular Ca
2 concentration (26). In this study, the
FK506 inhibitor is used to abrogate cytokine-induced Bad
dephosphorylation mediated by calcineurin. In other cell
systems, FK506 inhibits nuclear factor B–induced expres-
sion of inducible NO synthase (44). In rodent islets,
L-arginine analogues that block inducible NO synthase
activity inhibit cytokine-induced -cell death (1). How-
ever, NO plays only a minor role in cytokine-induced
apoptosis in human islets (1), and the molecular mecha-
nism underlying the protective effect of FK506 against
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most likely independent of inhibition of NO synthesis.
Exposure of -cells to a combination of IL-1 and IFN-
increases cytosolic Ca
2 levels via low-voltage–activated
Ca
2 channels (26). Antagonists of Ca
2 channels prevent
the rise in cytosolic Ca
2 and reduce cell death in cyto-
kine-treated -cells (16,26), suggesting a key role of Ca
2
in cytokine-induced cell death. Indeed, previous ﬁndings
suggested that IFN-– and TNF-–induced cell death may
be partially mediated by Ca
2-activated proteins such as
calpain or calcineurin (16). Our ﬁndings suggest that
calcineurin-mediated dephosphorylation of Bad Ser136
may provide a link between the rise in cytosolic Ca
2 and
the core death machinery in -cells upon cytokine
exposure.
Calcineurin-based immunosuppressants are known to
impair insulin production by blocking calcineurin-
mediated activation of the transcription factor nuclear
factor of activated T-cells (NFAT), and long-term exposure
is associated with decreased -cell survival (45–49). We
have previously suggested that the long-term negative
effect of calcineurin-based inhibitors on -cell survival
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survival (50). In the current study, we exposed -cells to
FK506 for a relatively short time period (25 h), and the
rationale for using FK506 in this study was solely to
examine its role on calcineurin-mediated Bad dephosphor-
ylation. Thus, it is entirely possible that the short-term
protective effects of FK506 against cytokine-mediated ap-
optosis are overshadowed by long-term toxicity.
In summary, our ﬁndings demonstrate that proinﬂam-
matory cytokines induce -cell apoptosis through the
canonical mitochondrial pathway and that this effect is
dependent on calcineurin-mediated Bad dephosphoryla-
tion and Bax activity. These results enhance our under-
standing of proapoptotic signaling induced by
proinﬂammatory cytokines in -cells and may provide the
basis for the development of future strategies for interven-
tion in type 1 diabetes and islet graft failure.
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